Neuronetics Inc. (STIM)
4.80
0.34 (7.62%)
At close: Feb 20, 2025, 3:59 PM
4.80
-0.10%
After-hours: Feb 20, 2025, 06:37 PM EST
undefined% (undefined)
| Bid | 4.77 |
| Market Cap | 192.53M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -1.22 |
| PE Ratio (ttm) | -3.94 |
| Forward PE | n/a |
| Analyst | Buy |
| Ask | 4.9 |
| Volume | 1,377,749 |
| Avg. Volume (20D) | 1,043,135 |
| Open | 4.90 |
| Previous Close | 4.46 |
| Day's Range | 4.55 - 4.97 |
| 52-Week Range | 0.52 - 5.07 |
| Beta | undefined |
About STIM
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, ...
Industry Medical - Diagnostics & Research
Sector Healthcare
IPO Date Jun 28, 2018
Employees 201
Stock Exchange NASDAQ
Ticker Symbol STIM
Website https://www.neurostar.com
Analyst Forecast
According to 4 analyst ratings, the average rating for STIM stock is "Buy." The 12-month stock price forecast is $3, which is a decrease of -37.57% from the latest price.
Buy 75.00%
Hold 25.00%
Sell 0.00%
Next Earnings Release
Neuronetics Inc. is scheduled to release its earnings on Mar 4, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 weeks ago
-13.76%
Neuronetics shares are trading lower after the com...
Unlock content with
Pro Subscription
2 weeks ago
+8.87%
Neuronetics shares are trading lower after the company announced a public offering, size not yet disclosed.
